Hologic FQ3 revenues up 3%; ytd cash flow down 20%

Hologic (NASDAQ:HOLX) fiscal Q3 results ($M): Revenues: 852.4 (+3.4%); Diagnostics: 305.4 (+3.8%); Breast Health: 325.4 (+5.7%).

Net income: 93.9 (-16.8%); non-GAAP net income: 171.6 (+7.9%); EPS: 0.35 (-14.6%); non-GAAP EPS: 0.63 (+8.6%).

Cash flow ops (9 mo.): 401.8 (-19.7%).

Fiscal Q4 guidance: Revenues: $834M – 849M; EPS: $0.39 – 0.41; non-GAAP EPS: $0.64 – 0.66.

Fiscal 2019 guidance: Revenues: $3.335B – 3.350B from $3.325B – 3.345B; EPS: $0.09 – 0.11 from $0.06 – 0.09; non-GAAP EPS: $2.42 – 2.44 from $2.41 – 2.44.

Shares down 1% after hours.

Previously: Hologic EPS beats by $0.02, beats on revenue (July 31)

https://seekingalpha.com/news/3484797-hologic-fq3-revenues-3-percent-ytd-cash-flow-20-percent